rs752762669
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM4PP5_Very_Strong
The NM_152618.3(BBS12):c.1531_1539delCAGATGCAA(p.Gln511_Gln513del) variant causes a conservative inframe deletion change. The variant allele was found at a frequency of 0.0000502 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_152618.3 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS12 | NM_152618.3 | c.1531_1539delCAGATGCAA | p.Gln511_Gln513del | conservative_inframe_deletion | Exon 2 of 2 | ENST00000314218.8 | NP_689831.2 | |
BBS12 | NM_001178007.2 | c.1531_1539delCAGATGCAA | p.Gln511_Gln513del | conservative_inframe_deletion | Exon 3 of 3 | NP_001171478.1 | ||
BBS12 | XM_011531680.3 | c.1531_1539delCAGATGCAA | p.Gln511_Gln513del | conservative_inframe_deletion | Exon 2 of 2 | XP_011529982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBS12 | ENST00000314218.8 | c.1531_1539delCAGATGCAA | p.Gln511_Gln513del | conservative_inframe_deletion | Exon 2 of 2 | 1 | NM_152618.3 | ENSP00000319062.3 | ||
BBS12 | ENST00000542236.5 | c.1531_1539delCAGATGCAA | p.Gln511_Gln513del | conservative_inframe_deletion | Exon 3 of 3 | 2 | ENSP00000438273.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251428Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135884
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461888Hom.: 0 AF XY: 0.0000468 AC XY: 34AN XY: 727244
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74362
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 12 Pathogenic:5
- -
- -
- -
- -
- -
Bardet-Biedl syndrome Pathogenic:2
This variant, c.1531_1539del, results in the deletion of 3 amino acid(s) of the BBS12 protein (p.Gln511_Gln513del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752762669, gnomAD 0.007%). This variant has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 17160889, 20120035; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 434492). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects BBS12 function (PMID: 20498079). For these reasons, this variant has been classified as Pathogenic. -
Variant summary: BBS12 c.1531_1539delCAGATGCAA (p.Gln511_Gln513del) results in an in-frame deletion that is predicted to remove three amino acids from the encoded protein. The variant allele was found at a frequency of 4e-05 in 251428 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in BBS12 causing Bardet-Biedl Syndrome (4e-05 vs 0.00076), allowing no conclusion about variant significance. c.1531_1539delCAGATGCAA has been reported in the literature in individuals affected with Bardet-Biedl Syndrome (Stoetzel_2006, Hjortshj_2010, Manara_2019). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and this variant affects protein function (Zaghloul_2010). The following publications have been ascertained in the context of this evaluation (PMID: 21463199, 31964843, 20120035, 30718709, 31196119, 20648243, 17160889, 20498079). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic (n=2) and likely pathogenic (n=5). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
BBS12-related disorder Pathogenic:1
The BBS12 c.1531_1539del9 variant is predicted to result in an in-frame deletion (p.Gln511_Gln513del). This variant was reported in individuals with Bardet-Biedl syndrome (Stoetzel et al 2007. PubMed ID: 17160889; Hjortshøj et al. 2010. PubMed ID: 20120035). Functional studies using zebrafish suggest that this variant is deleterious (Supp. Table 4, Zaghloul et al. 2010. PubMed ID: 20498079). This variant is reported in 0.0085% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. -
not provided Pathogenic:1
In-frame deletion of 3 amino acids in a non-repeat region; Published functional studies in zebrafish suggest a damaging effect (PMID: 20498079); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 30718709, 20120035, 17160889, 31196119, 20498079, 36938085, 31964843) -
Retinal dystrophy Pathogenic:1
- -
Retinitis pigmentosa Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at